Skip to main content

Patient Engagement in Preclinical Research

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Joletta Belton, MSc

    Joletta Belton, MSc, is a medically retired firefighter/paramedic who has lived with pain since January 2010. She is co-chair of IASP’s Global Alliance of Partners for Pain Advocacy and is the first Patient and Public Partnerships Editor at the Journal of Orthopaedic and Sports Physical Therapy. Her advocacy work centers on equitably integrating lived experience into the study, research, and treatment of pain. She has presented on this topic at pain conferences and in classrooms around the world and has authored and co-authored peer-reviewed journal articles and textbook chapters. She has also been a Patient Partner on research projects in Canada, Australia, and the UK.

  • Manoj Lalu, MD, PhD, FRCPC

    Manoj Lalu, MD, PhD, FRCPC, is an anesthesiologist and researcher focused on moving basic science discoveries to early phase clinical trials. He co-leads the Blueprint Translational Research Group in the Ottawa Hospital Research Institute at the University of Ottawa, Canada. The group adopts a variety of approaches to better understand and improve the "translational" process by optimizing preclinical to clinical translation (i.e., "bench-to-bedside"). At the bench, he believes this can be accomplished by improving methodological rigor and promoting transparent reporting. His research group is using knowledge synthesis methods (e.g., systematic reviews, systematic reviews/meta-research, qualitative interview studies, early economic analyses, preclinical lab studies, etc.) in order to improve translation of bench discoveries to first-in-human and early clinical trials. Moving to the bedside, he believes that interdisciplinary teams, including patients and other stakeholders, will help prevent failures and improve the efficiency of translation. His current research is largely preclinical and translational, focusing on cell therapies (e.g., mesenchymal stem cells, chimeric antigen receptor T-cells) for systemic inflammation that may be useful for cancer and cardiovascular disease.

  • Nadia Soliman, PhD

    Nadia Soliman, PhD, is a postdoctoral researcher in Andrew Rice’s Pain Group at Imperial College London, UK. She focuses on developing methods to improve the feasibility, efficiency, and accuracy of preclinical systematic reviews while addressing neurobiological questions of interest to improve the predictive validity of animal research, the use of machine technologies, and the employment of crowd science to ensure that research conduct is rigorous, open, and transparent. She is the UK Reproducibility Network’s Local Network Lead and Badges and Preprint Editor at BMJ Open Science. She also has an interest in sharing her military experiences and knowledge of leadership development to engender a more positive research culture.

November 28, 2022
Mon 11:00 AM EST

Duration 1H 0M

This live web event has ended.